P A Meyers, G Heller, V Vlamis. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdolescentAdultAge FactorsAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useBiomarkers, Tumor/bloodBleomycin/administration & dosageBone Neoplasms/bloodBone Neoplasms/drug therapyBone Neoplasms/mortalityBone Neoplasms/pathologyBone Neoplasms/surgeryChemotherapy, AdjuvantChildChild, PreschoolCisplatin/administration & dosageCombined Modality TherapyContinental Population GroupsCyclophosphamide/administration & dosageDactinomycin/administration & dosageDoxorubicin/administration & dosageFemaleHumansMaleMethotrexate/administration & dosageNew York/epidemiologyOsteosarcoma/bloodOsteosarcoma/drug therapyOsteosarcoma/mortalityOsteosarcoma/pathologyOsteosarcoma/surgeryPrognosisProportional Hazards ModelsRetrospective StudiesRiskSurvival RateTreatment Outcome
Substances： See more » Biomarkers, TumorBleomycinDactinomycinDoxorubicinCyclophosphamideCisplatinMethotrexate
Year: 1993 PMID： 7682091 DOI： 10.1007/978-1-4615-3518-8_37
Source DB: PubMed Journal: Cancer Treat Res ISSN： 0927-3042